![]() 3,4-二氢-2(1H)-喹啉酮结构式
![]() |
常用名 | 3,4-二氢-2(1H)-喹啉酮 | 英文名 | 3,4-Dihydroquinolin-2(1H)-one |
---|---|---|---|---|
CAS号 | 553-03-7 | 分子量 | 147.174 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 328.1±31.0 °C at 760 mmHg | |
分子式 | C9H9NO | 熔点 | 165-167ºC | |
MSDS | 美版 | 闪点 | 189.4±9.8 °C | |
符号 |
![]() GHS07 |
信号词 | Warning |
中文名 | 3,4-二氢-2(1H)-喹啉酮 |
---|---|
英文名 | 1,2,3,4-Tetrahydroquinolin-2-one |
中文别名 | 鄰胺氫桂皮酸內醯胺 | 2-氧-1,2,3,4-四氫喹啉 | 3,4-二氫-2(1H)-喹啉酮 | 氢化喹诺酮 |
英文别名 | 更多 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 328.1±31.0 °C at 760 mmHg |
熔点 | 165-167ºC |
分子式 | C9H9NO |
分子量 | 147.174 |
闪点 | 189.4±9.8 °C |
精确质量 | 147.068420 |
PSA | 29.10000 |
LogP | 1.34 |
外观性状 | 灰白色结晶粉末 |
蒸汽压 | 0.0±0.7 mmHg at 25°C |
折射率 | 1.564 |
储存条件 | 室温 |
符号 |
![]() GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302-H315-H317-H319-H335 |
警示性声明 | P261-P280-P305 + P351 + P338 |
危害码 (欧洲) | Xn:Harmful; |
风险声明 (欧洲) | R22;R36/37/38;R43 |
安全声明 (欧洲) | S26-S36/37 |
危险品运输编码 | UN 2811 |
WGK德国 | 2 |
包装等级 | III |
危险类别 | 6.1(b) |
3,4-二氢-2(1H)-喹啉酮上游产品 10 | |
---|---|
3,4-二氢-2(1H)-喹啉酮下游产品 10 | |
Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic.
Eur. J. Med. Chem. 79 , 216-30, (2014) The synthesis and sigma-1 receptor (1R) antagonist activity of a new series of 3,4-dihydro-2(1H)-quinolinone derivatives are reported. The new compounds were evaluated in vitro in sigma-1 and sigma-2 ... |
|
Novel approach to 3,4-dihydro-2(1H)-quinolinone derivatives via cyclopropane ring expansion.
Org. Lett. 11(5) , 1043-5, (2009) N-(1'-Alkoxy)cyclopropyl-2-haloanilines are transformed to 3,4-dihydro-2((1)H)-quinolinones via palladium-catalyzed cyclopropane ring expansion. The reaction tolerates a variety of functional groups s... |
|
Synthesis of 4-amino-3, 4-dihydro-2 (1H)-quinolinones via β-lactam intermediates on the solid-phase. Pei Y, et al.
Tetrahedron Lett. 38(19) , 3349-52, (1997)
|
Dihydro-α-quinolone |
3,4-Dihydroquinolin-2(1H)-one |
3,4-dihydro-1H-quinolin-2-one |
2(1H)-Quinolinone, 3,4-dihydro- |
MFCD00016722 |
3,4-Dihydro-2(1H)-quinolinone |
T66 BMVT&J |